Lexology November 26, 2025
NautaDutilh

AI, Intellectual Property, and strategic partnerships shaping the sector

The life sciences sector stands at the crossroads of rapid technological advancement and evolving legal landscapes. Against this backdrop, we convened our Life Sciences seminar on 28 October, bringing together experts and stakeholders to discuss the latest developments. As artificial intelligence transforms drug discovery and research, and as global partnerships become increasingly complex, stakeholders must navigate new challenges in intellectual property, licensing, and collaboration. This article explores the critical issues facing researchers, legal professionals, and industry leaders, providing timely insights for anyone operating at the intersection of science, technology, and law. Here are 5 things you need to know.

  • #1 2025 US IPO surge: Opportunities, challenges, and sector trends

    ...

Today's Sponsors

Venturous
ZeOmega

Today's Sponsor

Venturous

 
Topics: Biotechnology, Pharma / Biotech
What’s new with GLP-1s
Podcast: Medicaid vs. 340B: A Drug Pricing Clash (Sayeh Nikpay)
283: A candid conversation: Physicians on the front lines of GLP‑1 care
BigHat, Revvity Collaborate with Eli Lilly, Immunai Signs Agreement with Bristol Myers Squibb, SandboxAQ Launches New AI Model
Medicare Is Covering GLP-1s – It’s Time to Cover the Care That Makes Them Sustainable

Share Article